The Chicago Biomedical Consortium (CBC) is excited to share that AbbVie Ventures is launching the 2022 AbbVie Innovation Midwest (AIM) Award for a second year. The AIM Award is a program offering seed funding to emerging biotech companies in the Midwest in support of scientists, researchers, and biotech entrepreneurs working on novel science with the potential for transformational therapies.
To learn more details about the AIM Award and how to apply, please visit the webpage below. Application deadline is 11:59 PM CT on July 6, 2022.
https://www.abbvie.com/partnerships/abbvie-ventures/innovation-midwest-award.html